close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar0Point51
Implied share price

Buy Undervalued by 264.3%

5% margin of safety What's this?

EV / Total Assets
Use Average
BNC
Bioniche Life Sciences
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
2.23 0.07 1.82 2.23 4.44 0.55
All amounts in millions
from last financial year
         
Implied Share Price $0.51 $213.25 $81.91 $49.41 $171.94
Market Cap 40 130,102 107,921 100,042 98,744
Net Debt -38 47 7,450 -3,369 7,330
Enterprise Value (EV) 3 130,149 115,371 96,673 56,725
Revenue 0 21,662 32,639 13,418 34,861
Balance Sheet          
Total Assets 51 71,449 51,716 21,787 102,321
Total Liabilities 12 43,366 33,182 6,116 44,272
Shareholders Equity 38 28,083 18,534 15,671 58,049.0

Where are the revenue figures?

Certain companies do not report financial results at the revenue line. For these companies where Valuecruncher does not have revenue numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.